Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Infusion Safety”

1,197 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,197 results

Early research (Phase 1)Study completedNCT03409627
What this trial is testing

Novel INXN-4001 Triple Effector Plasmid in Heart Failure

Who this might be right for
Heart FailureCardiovascular DiseasesHeart-Assist Device
Triple-Gene, LLC 12
Not applicableStudy completedNCT04427605
What this trial is testing

Efficacy and Safety of Continuous Infusion of Ketamine in Pediatric Intensive Care Unit (KISS Study)

Who this might be right for
AnalgesiaKetamine ToxicityBronchospasm+1 more
Azienda Ospedaliera di Padova 57
Early research (Phase 1)Study completedNCT00016237
What this trial is testing

Interleukin-2 Combined With Monoclonal Antibody Therapy in Treating Patients With Kidney, Bladder, or Lung Cancer That Has Not Responded to Previous Treatment

Who this might be right for
Bladder CancerKidney CancerLung Cancer
EMD Serono
Not applicableStudy completedNCT05824039
What this trial is testing

Safety and Efficacy of Medicinal Plant Extract in Overweight and Obese Participants.

Who this might be right for
OverweightObesity
Laouani Aicha 98
Early research (Phase 1)Study completedNCT02693366
What this trial is testing

Stem Cell Therapy for Patients With Focal Segmental Glomerulosclerosis

Who this might be right for
Focal Segmental GlomerulosclerosisChronic Kidney Diseases
Universidade Federal do Rio de Janeiro 5
Testing effectiveness (Phase 2)Active Not RecruitingNCT03867617
What this trial is testing

Cell Therapy for Immunomodulation in Kidney Transplantation

Who this might be right for
Kidney Transplantation
Thomas Wekerle 12
Testing effectiveness (Phase 2)Study completedNCT02675465
What this trial is testing

First-In-Human Study to Evaluate Safety, Tolerability, and PK of Intravenous ATB200 Alone and When Co-Administered With Oral AT2221

Who this might be right for
Pompe Disease
Amicus Therapeutics 29
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07769671
What this trial is testing

Human Umbilical Cord Mesenchymal Stem Cell Infusion for Type 2 Diabetic Nephropathy

Who this might be right for
Diabetic Nephropathy Type 2
The First People's Hospital of Changzhou 49
Post-approval studies (Phase 4)Study completedNCT00357656
What this trial is testing

Phase 3/4 Study of a Recombinant Protein-Free Factor VIII (rAHF-PFM): Comparison of Continuous Infusion Versus Intermittent Bolus Infusion in Hemophilia A Subjects Undergoing Major Orthopedic Surgery

Who this might be right for
Hemophilia A
Baxalta now part of Shire 85
Early research (Phase 1)Study completedNCT06105528
What this trial is testing

A Phase 1a Study of PMN310 In Healthy Volunteers

Who this might be right for
Healthy Participants
ProMis Neurosciences, Inc 40
Early research (Phase 1)Looking for participantsNCT06674265
What this trial is testing

Safety and Efficacy of Systemic Allogenic NK Cells in R/R Neuroblastoma

Who this might be right for
Neuroblastoma, Recurrent, RefractoryNeuroblastoma (NB)Neuroblastoma in Children
Marzieh Ebrahimi 10
Early research (Phase 1)UnknownNCT05019534
What this trial is testing

Tolerability and Safety of Vemurafenib, Cetuximab Combined With Camrelizumab for BRAF V600E-mutated /MSS Metastatic Colorectal Cancer

Who this might be right for
BRAF V600E-mutated /MSS Metastatic Colorectal CancerVemurafenib (BRAFi) Plus Cetuximab (EGFRi) Combined With PD-1 Monoclonal Antibody
West China Hospital 12
Early research (Phase 1)Ended earlyNCT01529307
What this trial is testing

First in Human Trial of TAS266 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Novartis Pharmaceuticals 6
Not applicableEnded earlyNCT04150367
What this trial is testing

Efficacy and Safety of Intravenous Treatment of Tuberculosis

Who this might be right for
Tuberculosis, Pulmonary
Yuria-Pharm 166
Large-scale testing (Phase 3)WithdrawnNCT02782481
What this trial is testing

A Clinical Study Investigating the Efficacy, Tolerability, and Safety of Continuous Subcutaneous ND0612 Infusion Given as Adjunct Treatment to Oral Levodopa in Patients With Parkinson's Disease With Motor Fluctuations

Who this might be right for
Parkinson's Disease
NeuroDerm Ltd.
Large-scale testing (Phase 3)Study completedNCT00571636
What this trial is testing

Continuous Infusion of Fentanyl in Preterm on MV

Who this might be right for
PainInfant, Premature, DiseasesRespiration; Insufficient or Poor, Newborn
IRCCS Azienda Ospedaliero-Universitaria di Bologna 128
Testing effectiveness (Phase 2)WithdrawnNCT00313807
What this trial is testing

Study of Intravenous Amino Acid Infusion to Prevent Contrast Dye Mediated Renal Damage

Who this might be right for
Contrast NephropathyRenal Failure
Queen's University
Testing effectiveness (Phase 2)UnknownNCT05214339
What this trial is testing

A Trial of Hepatic Arterial Infusion Combined With Bevacizumab and Sintilimab for Unresectable A-staged Hepatocellular Carcinoma in BCLC Classification (D-TRIPLET)

Who this might be right for
Unresectable Hepatocellular CarcinomaHepatocellular Carcinoma by BCLC Stage
Sun Yat-sen University 30
Testing effectiveness (Phase 2)Study completedNCT01221467
What this trial is testing

Closing the Loop in Youth With Type 1 Diabetes in the Home Setting

Who this might be right for
Type 1 Diabetes
University of Cambridge 17
Early research (Phase 1)Study completedNCT01011972
What this trial is testing

Intravenous XMT-1107 in Patients With Advanced Solid Tumors

Who this might be right for
Neoplasm Metastasis
Mersana Therapeutics 52
Next Page